Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism

IntroductionIt is unclear how drug-interaction with apixaban influences recurrent venous thromboembolism (VTE) and bleedings in cancer patients.MethodsA post-hoc analysis of a single-arm interventional clinical trial on apixaban treatment of cancer patients with VTE to investigate whether the occurr...

Full description

Saved in:

Bibliographic Details
Main Authors:	Marte Svalastoga, Trine-Lise Larsen, Jorunn Brekke, Tone Enden, Hege Frøen, Herish Garresori, Eva Marie Jacobsen, Alina Carmen Porojnicu, Anne Hansen Ree, Dag Torfoss, Elin Osvik Velle, Hilde Skuterud Wik, Waleed Ghanima, Per Morten Sandset, Anders Erik Astrup Dahm
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-01-01
Series:	Frontiers in Oncology
Subjects:	venous thromboembolism apixaban cancer drug-drug interaction bleeding
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1520725/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism

Similar Items